Vascular Surgery Innovation Over Three Decades: An Analysis of Food and Drug Administration Device Approvals

被引：0
|
作者：
Wiske, Clay [1 ]
Barfield, Michael E. [2 ]
Suh, Insoo [1 ]
Schneider, Peter A.
Maldonado, Thomas S. [3 ]
机构：
[1] New York Univ, New York, NY USA
[2] Univ Tennessee Hlth Sci Ctr, Chattanooga, TN USA
[3] New York Univ Langone Med Ctr, New York, NY USA
来源：
JOURNAL OF VASCULAR SURGERY | 2023年 / 77卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
IP153
引用
收藏
页码：E169 / E169
页数：1
相关论文
共 50 条
  • [21] New for 2022: Food and Drug Administration Approvals of Pediatric Respiratory Medications
    Bickel, Scott
    Eid, Nemr
    Delaney, Matthew
    Morton, Ronald
    PEDIATRIC ALLERGY IMMUNOLOGY AND PULMONOLOGY, 2023, 36 (02) : 37 - 40
  • [22] Food and Drug Administration approvals in phase 3 Cancer clinical trials
    Joseph Abi Jaoude
    Ramez Kouzy
    Marc Ghabach
    Roshal Patel
    Dario Pasalic
    Elie Ghossain
    Austin B. Miller
    Timothy A. Lin
    Vivek Verma
    C. David Fuller
    Vivek Subbiah
    Bruce D. Minsky
    Ethan B. Ludmir
    Cullen M. Taniguchi
    BMC Cancer, 21
  • [23] Food and Drug Administration approvals in phase 3 Cancer clinical trials
    Jaoude, Joseph Abi
    Kouzy, Ramez
    Ghabach, Marc
    Patel, Roshal
    Pasalic, Dario
    Ghossain, Elie
    Miller, Austin B.
    Lin, Timothy A.
    Verma, Vivek
    Fuller, C. David
    Subbiah, Vivek
    Minsky, Bruce D.
    Ludmir, Ethan B.
    Taniguchi, Cullen M.
    BMC CANCER, 2021, 21 (01)
  • [24] Limitations in Clinical Trials Leading to Anticancer Drug Approvals by the US Food and Drug Administration
    Hilal, Talal
    Gonzalez-Velez, Miguel
    Prasad, Vinay
    JAMA INTERNAL MEDICINE, 2020, 180 (08) : 1108 - 1115
  • [25] Single-arm trials for US Food and Drug Administration cancer drug approvals
    Nierengarten, Mary Beth
    CANCER, 2023, 129 (11) : 1626 - 1627
  • [26] Analysis of US Food and Drug Administration new drug and biologic approvals, regulatory pathways, and review times, 1980–2022
    Enrique Seoane-Vazquez
    Rosa Rodriguez-Monguio
    John H. Powers
    Scientific Reports, 14
  • [27] The impact of external innovation on new drug approvals: A retrospective analysis
    Liu, Xiong
    Thomas, Craig E.
    Felder, Christian C.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, 563 : 273 - 281
  • [28] Surgical Innovation and the US Food and Drug Administration
    Cundiff, Geoffrey W.
    FEMALE PELVIC MEDICINE AND RECONSTRUCTIVE SURGERY, 2019, 25 (04): : 263 - 264
  • [29] Analysis of US Food and Drug Administration Oncology Approvals on the Characterization of Hepatic Impairment Effect and Dosing Recommendations
    Yang, Derek Z.
    Alhadab, Ali
    Parivar, Kourosh
    Wang, Diane D.
    Elmeliegy, Mohamed
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 112 (04) : 782 - 790
  • [30] New US Food and Drug Administration Approvals Decrease Generic Flucytosine Costs
    Rajasingham, Radha
    Boulware, David R.
    CLINICAL INFECTIOUS DISEASES, 2019, 69 (04) : 732 - 732
12345